Progress and Challenges in the Understanding of Chronic Urticaria

Allergy, Asthma & Clinical Immunology

Marta Ferrer¹  Allen P Kaplan² 

[1] Department of Allergy, Clinica Universitaria, Universidad de Navarra, Pamplona, Spain

[2] National Allergy, Asthma, and Urticaria Centers of Charleston, Charleston, South Carolina

关键词: mast cells;    IgE receptor;    cotinine;    chronic urticaria;    basophils;    autoimmunity;   

Others  :  1083828
DOI  :  10.1186/1710-1492-3-1-31

【 授权许可】

   
2007 Canadian Society of Allergy and Clinical Immunology

【 参考文献 】

• [1]Gaig P, Olona M, Muñoz Lejarazu D, et al.: Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 2004, 14:342-5.
• [2]O'Donnell BF, Lawlor F, Simpson J, et al.: The impact of chronic urticaria on the quality of life. Br J Dermatol 1997, 136:197-201.
• [3]Grob JJ, Gaudy-Marqueste C: Urticaria and quality of life. Clin Rev Allergy Immunol 2006, 30:47-51.
• [4]Leznoff A, Josse RG, Denburg J, Dolovich J: Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983, 119:636-40.
• [5]Gruber BL, Baeza ML, Marchese MJ, et al.: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988, 90:213-7.
• [6]Hide M, Francis DM, Grattan CE, et al.: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599-604.
• [7]Niimi N, Francis DM, Kermani F, et al.: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996, 106:1001-6.
• [8]Ferrer M, Kinet JP, Kaplan AP: Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998, 101:672-6.
• [9]Ferrer M, Nakazawa K, Kaplan AP: Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999, 104:169-72.
• [10]Kikuchi Y, Kaplan AP: A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002, 109:114-8.
• [11]Sabroe RA, Grattan CE, Francis DM, et al.: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446-52.
• [12]Fiebiger E, Hammerschmid F, Stingl G, Maurer D: Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998, 101:243-51.
• [13]Kikuchi Y, Kaplan AP: Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001, 107:1056-62.
• [14]Horn MP, Gerster TF, Ochensberger BF, et al.: Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999, 29:1139-48.
• [15]Pachlopnik JM, Horn MP, Fux M, et al.: Natural anti-Fc[epsiv]RI[alpha] autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004, 22:43-51.
• [16]Horn MP, Pachlopnik JM, Vogel M, et al.: Conditional autoimmunity mediated by human natural anti-FceRIa autoantibodies? FASEB J 2001, 15:2268-74.
• [17]Sabroe RA, Fiebiger E, Francis DM, et al.: Classification of anti- FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002, 110:492-9.
• [18]Ferrer M, Luquin E, Kaplan AP: IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy 2003, 58:802-7.
• [19]Puccetti A, Bason C, Simeoni S, et al.: In chronic idiopathic urticaria autoantibodies against FceRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005, 35:1599-607.
• [20]O'Donnell BF, O'Neill CM, Francis DM, et al.: Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999, 140:853-8.
• [21]Ferrer M, Luquin E, Sanchez-Ibarrola A, et al.: Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol 2002, 129:254-60.
• [22]Yasnowsky KM, Dreskin SC, Efaw B, et al.: Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006, 117:1430-4.
• [23]Stewart GE: Histopathology of chronic urticaria. Clin Rev Allergy Immunol 2002, 23:195-200.
• [24]Natbony SF, Phillips ME, Elias JM, et al.: Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983, 71:177-83.
• [25]Hermes B, Prochazka AK, Haas N, et al.: Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999, 103:307-14.
• [26]Haas N, Toppe E, Henz BM: Microscopic morphology of different types of urticaria. Arch Dermatol 1998, 134:41-6.
• [27]Ying S, Kikuchi Y, Meng Q, et al.: TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002, 109:694-700.
• [28]Openshaw P, Murphy EE, Hosken NA, et al.: Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995, 182:1357-67.
• [29]Barlow RJ, Ross EL, MacDonald DM, et al.: Mast cells and T lymphocytes in chronic urticaria. Clin Exp Allergy 1995, 25:317-22.
• [30]Grattan CE, Sabroe RA, Greaves MW: Chronic urticaria. J Am Acad Dermatol 2002, 46:645-57.
• [31]Grattan CE, Walpole D, Francis DM, et al.: Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997, 27:1417-24.
• [32]Plaut M, Kazimierczak W, Lichtenstein LM: Abnormalities of basophil "releasability" in atopic and asthmatic individuals. J Allergy Clin Immunol 1986, 78:968-73.
• [33]Lawrence ID, Warner JA, Cohan VL, et al.: Bradykinin analog induces histamine release from human skin mast cells. Adv Exp Med Biol 1989, 247:225-9.
• [34]Alam R, Forsythe P, Stafford S, et al.: Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J Immunol 1994, 153:3155-9.
• [35]Fureder W, Agis H, Willheim M, et al.: Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995, 155:3152-60.
• [36]Luquin E, Kaplan AP, Ferrer M: Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 2005, 35:456-60.
• [37]Kern F, Lichtenstein LM: Defective histamine release in chronic urticaria. J Clin Invest 1976, 57:1369-77.
• [38]Bischoff SC, Zwahlen R, Stucki M, et al.: Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma. Int Arch Allergy Immunol 1996, 110:261-71.
• [39]Greaves MW, Plummer VM, McLaughlan P, Stanworth DR: Serum and cell bound IgE in chronic urticaria. Clin Allergy 1974, 4:265-71.
• [40]Wahn U, Ernsting M, Peterson J: Spontaneous histamine release from washed leukocytes and whole blood in atopic and non-atopic individuals. Allergy 1990, 45:109-14.
• [41]Zuberbier T, Schwarz S, Hartmann K, et al.: Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy 1996, 51:24-8.
• [42]Alam R, Lett-Brown MA, Forsythe PA, et al.: Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest 1992, 89:723-8.
• [43]Confino-Cohen R, Aharoni D, Goldberg A, et al.: Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 2002, 109:349-56.
• [44]Grattan CE, Dawn G, Gibbs S, Francis DM: Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003, 33:337-41.
• [45]Sabroe RA, Poon E, Orchard GE, et al.: Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol 1999, 103:484-93.
• [46]Marsland AM, Soundararajan S, Joseph K, Kaplan AP: Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy 2005, 35:554-9.
• [47]O'Donnell BF, Barr RM, Black AK, et al.: Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998, 138:101-6.
• [48]Kessel A, Bamberger E, Toubi E: Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol 2005, 52:145-8.